Reply to "Usefulness of Plasma Amyloid as Prescreener of the Earliest Alzheimer Pathological Changes Depends on the Study Population".

Verberk, Inge M W; Teunissen, Charlotte E; Van der Flier, Wiesje M

Verberk, Inge M W; Teunissen, Charlotte E; Van der Flier, Wiesje M.

Afiliação

Verberk IMW; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam University Medical Center, Amsterdam, the Netherlands.
Teunissen CE; Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam University Medical Center, Amsterdam, the Netherlands.
Van der Flier WM; Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam University Medical Center, Amsterdam, the Netherlands.

Ann Neurol ; 87(1): 155, 2020 01.

Article em En | MEDLINE | ID: mdl-31675120

Assuntos

Doença de Alzheimer; Amiloidose; Amiloide; Peptídeos beta-Amiloides; Humanos; Plasma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Alzheimer / Amiloidose Limite: Humans Idioma: En Revista: Ann Neurol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Holanda

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google